Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181 - PubMed (original) (raw)

. 2006 Dec 15;66(24):11590-3.

doi: 10.1158/0008-5472.CAN-06-3613.

Urmila Santanam, Amelia Cimmino, Alexey Palamarchuk, Alexey Efanov, Vadim Maximov, Stefano Volinia, Hansjuerg Alder, Chang-Gong Liu, Laura Rassenti, George A Calin, John P Hagan, Thomas Kipps, Carlo M Croce

Affiliations

• PMID: 17178851
• DOI: 10.1158/0008-5472.CAN-06-3613

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181

Yuri Pekarsky et al. Cancer Res. 2006.

Abstract

B-cell chronic lymphocytic leukemia (B-CLL) is the most common human leukemia in the world. Deregulation of the TCL1 oncogene is a causal event in the pathogenesis of the aggressive form of this disease as was verified by using animal models. To study the mechanism of Tcl1 regulation in CLL, we carried out microRNA expression profiling of three types of CLL: indolent CLL, aggressive CLL, and aggressive CLL showing 11q deletion. We identified distinct microRNA signatures corresponding to each group of CLL. We further determined that Tcl1 expression is regulated by miR-29 and miR-181, two microRNAs differentially expressed in CLL. Expression levels of miR-29 and miR-181 generally inversely correlated with Tcl1 expression in the CLL samples we examined. Our results suggest that Tcl1 expression in CLL is, at least in part, regulated by miR-29 and miR-181 and that these microRNAs may be candidates for therapeutic agents in CLLs overexpressing Tcl1.

PubMed Disclaimer

Similar articles

• TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia.
  Balatti V, Rizzotto L, Miller C, Palamarchuk A, Fadda P, Pandolfo R, Rassenti LZ, Hertlein E, Ruppert AS, Lozanski A, Lozanski G, Kipps TJ, Byrd JC, Croce CM, Pekarsky Y. Balatti V, et al. Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):2169-74. doi: 10.1073/pnas.1500010112. Epub 2015 Feb 2. Proc Natl Acad Sci U S A. 2015. PMID: 25646413 Free PMC article.
• The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia.
  Calin GA, Pekarsky Y, Croce CM. Calin GA, et al. Best Pract Res Clin Haematol. 2007 Sep;20(3):425-37. doi: 10.1016/j.beha.2007.02.003. Best Pract Res Clin Haematol. 2007. PMID: 17707831 Review.
• Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
  Mittal AK, Hegde GV, Aoun P, Bociek RG, Dave BJ, Joshi AD, Sanger WG, Weisenburger DD, Joshi SS. Mittal AK, et al. Int J Mol Med. 2007 Oct;20(4):461-9. Int J Mol Med. 2007. PMID: 17786276
• Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice.
  Zanesi N, Aqeilan R, Drusco A, Kaou M, Sevignani C, Costinean S, Bortesi L, La Rocca G, Koldovsky P, Volinia S, Mancini R, Calin G, Scott CP, Pekarsky Y, Croce CM. Zanesi N, et al. Cancer Res. 2006 Jan 15;66(2):915-20. doi: 10.1158/0008-5472.CAN-05-3426. Cancer Res. 2006. PMID: 16424025
• New insights into the pathogenesis of chronic lymphocytic leukemia.
  Klein U, Dalla-Favera R. Klein U, et al. Semin Cancer Biol. 2010 Dec;20(6):377-83. doi: 10.1016/j.semcancer.2010.10.012. Epub 2010 Oct 26. Semin Cancer Biol. 2010. PMID: 21029776 Review.

Cited by

• Identifying microRNAs involved in degeneration of the organ of corti during age-related hearing loss.
  Zhang Q, Liu H, McGee J, Walsh EJ, Soukup GA, He DZ. Zhang Q, et al. PLoS One. 2013 Apr 30;8(4):e62786. doi: 10.1371/journal.pone.0062786. Print 2013. PLoS One. 2013. PMID: 23646144 Free PMC article.
• Non-Coding RNAs: The "Dark Side Matter" of the CLL Universe.
  Lingua MF, Carrà G, Maffeo B, Morotti A. Lingua MF, et al. Pharmaceuticals (Basel). 2021 Feb 21;14(2):168. doi: 10.3390/ph14020168. Pharmaceuticals (Basel). 2021. PMID: 33669945 Free PMC article. Review.
• Targeting microRNA in hematologic malignancies.
  Han Z, Rosen ST, Querfeld C. Han Z, et al. Curr Opin Oncol. 2020 Sep;32(5):535-544. doi: 10.1097/CCO.0000000000000657. Curr Opin Oncol. 2020. PMID: 32657797 Free PMC article. Review.
• Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.
  Zhao A, Zhou H, Yang J, Li M, Niu T. Zhao A, et al. Signal Transduct Target Ther. 2023 Feb 17;8(1):71. doi: 10.1038/s41392-023-01342-6. Signal Transduct Target Ther. 2023. PMID: 36797244 Free PMC article. Review.
• Molecular basis of CLL.
  Pekarsky Y, Zanesi N, Croce CM. Pekarsky Y, et al. Semin Cancer Biol. 2010 Dec;20(6):370-6. doi: 10.1016/j.semcancer.2010.09.003. Epub 2010 Sep 21. Semin Cancer Biol. 2010. PMID: 20863894 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations Database